NL-OMON38647
Completed
Not Applicable
Supporting primary care in diagnosis and choice of treatment for patients with psychosocial symptoms: SGE-PsyScan. - SGE-PsyScan
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Maastricht University
- Enrollment
- 648
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with (suspected) psychosocial symptoms
- •Aged 18 years or older and capacitated
- •Adequate understanding of Dutch language
- •Able to perform SGE\-PsyScan at home, individually
Exclusion Criteria
- •Clear and treatable somatic causes of symptoms
- •Acute distress/danger
- •No written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Development of effective primary care treatment of severe sleep disorders in children with a learning disability; a randomised controlled trialSleep disorderslearning disabilityMental and Behavioural DisordersNonorganic sleep disordersISRCTN84194243HS R&D Regional Programme Register - Department of Health (UK)66
Recruiting
Not Applicable
Primary care diagnostics or diagnostics in a memory clinic in older persons with memory complaints - A long-term cost-effectiveness trial with non-inferiority desigdementiamemory problems10012272NL-OMON53325Radboud Universitair Medisch Centrum294
Active, not recruiting
Not Applicable
Comparing dementia diagnostics in primary care and in memory clinics: which makes older patients fare better in the long term?Persons aged 70 years and older with memory complaintsMental and Behavioural DisordersISRCTN18043557Radboud University Nijmegen Medical Centre294
Completed
Not Applicable
Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.Mental DisordersNCT01971307Maastricht University Medical Center336
Completed
Not Applicable
tritional Support in Patients with newly diagnosed oEsophageal CancerISRCTN28490479Danone Research (Netherlands)67